Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373903 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
B-Raf kinase plays a critical role in the Raf-MEK-ERK signaling pathway and inhibitors of B-Raf could be used in the treatment of melanomas, colorectal cancer, and other Ras related human cancers. We have identified novel small molecule pyrazolo[1,5-a]pyrimidine derivatives as B-Raf kinase inhibitors. Structure–activity relationship was generated for various regions of the scaffold to improve the biochemical profile.
Graphical abstractIdentification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase Inhibitor and the SAR requirements are reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ariamala Gopalsamy, Greg Ciszewski, Yongbo Hu, Frederick Lee, Larry Feldberg, Eileen Frommer, Steven Kim, Karen Collins, Donald Wojciechowicz, Robert Mallon,